Creotech Instruments (CRI) Q2 2026 earnings summary

Executive summary

• Revenue from continuing operations for H1 2026 reached 84.1m PLN, up 21.2m PLN year-over-year, mainly due to milestone completion in the Mikroglob project.

• Operating costs rose by 28.9m PLN, driven by higher employment, social security, and subcontractor costs in key projects.

• Net profit from continuing operations was 286k PLN for H1 2026, compared to 6.2m PLN a year earlier.

• A significant one-off gain of 683.1m PLN was recognized from the spin-off and distribution of the quantum systems segment.

• The company completed a public offering in July 2026, raising 481m PLN to fund its 2026-2029 strategy.

Financial highlights

• Total revenue for H1 2026: 89.6m PLN (including discontinued operations), up from 67.9m PLN year-over-year.

• Operating loss from continuing operations: -945k PLN (vs. 7.5m PLN profit in H1 2025).

• Net profit for the period: 685.3m PLN, driven by the non-cash gain from the spin-off.

• Cash flow from operations: -78.4m PLN (vs. +54.8m PLN in H1 2025); cash at period end: 29.4m PLN.

• Equity at 30 June 2026: 151.2m PLN; total assets: 315.4m PLN.

Outlook and guidance

• Future results will be influenced by milestone timing in large projects, especially Mikroglob.

• The company expects significant impact from new ESA contracts and the deployment of capital raised in July 2026.

• No financial forecasts were published.